Global Immune Repertoire Sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Immune Repertoire Sequencing Market Research Report 2024
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
According to MRAResearch’s new survey, global Immune Repertoire Sequencing market is projected to reach US$ 128.8 million in 2033, increasing from US$ 103.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immune Repertoire Sequencing market research.
Key companies engaged in the Immune Repertoire Sequencing industry include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immune Repertoire Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immune Repertoire Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immune Repertoire Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Bioinformatics
Hematology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immune Repertoire Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Immune Repertoire Sequencing market is projected to reach US$ 128.8 million in 2033, increasing from US$ 103.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immune Repertoire Sequencing market research.
Key companies engaged in the Immune Repertoire Sequencing industry include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immune Repertoire Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immune Repertoire Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immune Repertoire Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Segment by Application
Bioinformatics
Hematology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immune Repertoire Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source